Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
| NAV as of Oct 20, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
|---|---|---|---|
| ₹43.835+0.81% 1 day change | 23.92% p.a. | App exclusive | ₹3,074 Cr |
| Expense ratio | 0.6% as on Sep 30, 2025 |
| Exit load | 0.5% Exit load of 0.50% if redeemed within 1 month.! |
| AUM (Fund size) | ₹3,074 Cr |
| Lock-in Period | Nil |
| Age | 6 yrs 11 m since Nov 12, 2018 |
| Benchmark | BSE Healthcare TRI |
| Min. investment | SIP: ₹500 & Lumpsum: ₹1000 |
| Risk | Very High |
| Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
| Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
| Period | This fund | Category average |
|---|---|---|
| 1 Month | 2.38% | 2.25% |
| 3 Months | -1.48% | -0.39% |
| 6 Months | 7.57% | 8.17% |
| 1 Year | 1.35% | 5.6% |
| 2 Years | 25.85% | 28.22% |
| 3 Years | 24.36% | 24.61% |
| 4 Years | 16.7% | 16.84% |
| 5 Years | 19.74% | 19.57% |

Large Cap 29.7%
Mid Cap 20.22%
Small Cap 48.02%
Other Cap 0%
Healthcare 95.78000000000002%
Insurance 1.48%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Foreign - Equity 12.640000000000002%
Reverse Repo 2.34%
Foreign Mutual Funds 0.69%
Others 2.34%
Global X Genomics & Biotechnology ETF 0.69%

| Alpha | 2.8 vs. 5.94 Underperformed at beating benchmark |
| Sharpe | 1.12 vs. 4.0 Poor risk-adjusted returns |
| Beta | 0.84 vs. 0.72 More sensitive to market's ups & downs |
| Standard deviation | 14.69 vs. 9.14 More volatile performance |
| Fund AUM | 3,074 Cr as on Sep 30, 2025 |
| Scheme document | View Scheme Document |
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
| No. of schemes | 54 view all schemes |
| Total AUM | 2,12,960 Cr as on Sep 30, 2025 |
| Address | NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road Junction Western Express Highway, Andheri East Mumbai, 400069 |
| Phone | 1800-208-4499 / 1800-200-4499 |
| Fund name | ETM Rank | AUM | 1Y | 5Y |
|---|---|---|---|---|
| DSP India T.I.G.E.R. Fund | N.A. | 5,390 Cr | 0.74% | 33.95% |
| DSP Natural Resources and New Energy Fund | N.A. | 1,391 Cr | 6.38% | 28.36% |
| DSP Small Cap Fund | N.A. | 16,496 Cr | 3.67% | 27.32% |
| DSP ELSS Tax Saver Fund | N.A. | 16,749 Cr | 5.88% | 24.52% |
| DSP Large & Mid Cap Fund | N.A. | 15,857 Cr | 5.73% | 24.03% |
| DSP Nifty 50 Equal Weight Index Fund | N.A. | 2,285 Cr | 9.26% | 23.78% |
The current Net Asset Value (NAV) of the DSP Healthcare Fund - Direct Growth plan is approximately ₹43.835 as of Oct 20, 2025.
The DSP Healthcare Fund Direct - Growth is a 6 yrs 11 m old fund and has delivered average annual returns of 23.92% since inception.
| 1-Year | 3-Year | 5-Year | Since Inception |
|---|---|---|---|
| 1.35% | 24.36% | 19.74% | 23.92% |
The DSP Healthcare Fund - Direct Growth has an expense ratio of 0.6%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The DSP Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately 3,074 Cr as on Sep 30, 2025.
The DSP Healthcare Fund has invested the majority of its money in the stocks of the following companies -
| Company | Percentage of Portfolio |
|---|---|
| Cipla Ltd. | 8.76% |
| Sun Pharmaceutical Industries Ltd. | 7.96% |
| Cohance Lifesciences Ltd. | 7.9% |
| Ipca Laboratories Ltd. | 7.39% |
| Laurus Labs Ltd. | 6.07% |
| Gland Pharma Ltd. | 5.96% |
| Sai Life Sciences Ltd. | 4.77% |
| Apollo Hospitals Enterprise Ltd. | 4.69% |
| Globus Medical Inc | 4.45% |
| Illumina Inc. (USA) | 4.4% |
The DSP Healthcare Fund has primarily invested in the following sectors
| Sector | Percentage of Portfolio |
|---|---|
| Healthcare | 95.78000000000002% |
| Insurance | 1.48% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
It is very fast, easy, and completely paperless in this mutual fund scheme on ET Money. The whole process takes just a few minutes. Here's how it works:
For the Desktop Version:
For the Mobile Version:
That's it. Your investment in the DSP Healthcare Fund is complete.
Redeeming your investments in the DSP Healthcare Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.
